Cort August Little, PA-C

Cort Little practices at Northeast Florida Endocrine and Diabetes Associates PA in Jacksonville, Florida.

Cort Little's NPI, 1710760061, was assigned on August 18, 2023. Cort Little holds Florida license PA9117859.

Cort Little's primary practice is Northeast Florida Endocrine and Diabetes Associates PA, at 915 Monroe W St, Jacksonville, FL 32204 in Duval County. The practice phone is (904) 384-2240.

Cort Little's primary practice is Northeast Florida Endocrine and Diabetes Associates PA in Jacksonville, Florida. Cort Little is also affiliated with Baptist Medical Center Jacksonville. The medical group on file is Northeast Florida Endocrine and Diabetes Associates. Dmand AI also links Cort Little to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Cort Little practices, 7 sites in all. Vendor and product names are available with a free account.

Physician assistant is Cort Little's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Cort Little is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Cort Little is licensed in Florida.

CMS data shows 1,209 Medicare services from Cort Little across 5 procedure codes in 2024, for 654 Medicare patients. Medicare paid $66,698 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 654 Medicare patients who saw Cort Little in 2024. The largest group is 75 to 84, with 272 patients. 75% of them have diabetes, and 75% have high blood pressure. 21% are also on Medicaid. Their average risk score is 3.13, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Cort Little's median patient age at 66, with 58% women.

In 2024, Cort Little wrote 244 Medicare Part D claims for 109 patients. 14% of them were for generic drugs. CMS names the drug for 104 of them, across 5 drugs with 11 or more claims each, at $41,500 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Cort Little for performance year 2024, reported through an alternative payment model (APM). Cort Little accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Cort Little as offering telehealth.

CMS Open Payments shows 75 general payments to Cort Little from 22 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $580.

Cort Little is a member of AAPA and ASEPA.